Hyukjun Lee

Dr. Hyukjun Lee

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2023 in Medicina
Verified
Journal Article
Open access
PDF file
HLHyukjun Lee
Hyukjun Lee
JJJunwoo Jang
Junwoo Jang
HKHYO SHIN KANG
HYO SHIN KANG
JLJakyung Lee
Jakyung Lee
DLDaseul Lee
Daseul Lee
Woojae MyungWoojae Myung
Woojae Myung
Background and Objectives: Depressive symptoms are prominent in both major depressive disorder (MDD) and bipolar disorder (BD). However, comparative research on the network structure of depressive symptoms in these two diagnostic groups has been limited. This study aims to compare the network structure of depressive symptoms in MDD and BD, providing a deeper understanding of the depressive symptomatology of each disorder. Materials and Methods: The Zung Self-Rating Depressive Scale, a 20-item questionnaire, was administered to assess the depressive symptoms in individuals with MDD (n = 322) and BD (n = 516). A network analysis was conducted using exploratory graph analysis (EGA), and the network structure was analyzed using regularized partial correlation models. To validate the dimensionality of the Zung SDS, principal component analysis (PCA) was adopted. Centrality measures of the depressive symptoms within each group were assessed, followed by a network comparison test between the two groups. Results: In both diagnostic groups, the network analysis revealed four distinct categories, aligning closely with the PCA results. “Depressed affect” emerged as the most central symptom in both MDD and BD. Furthermore, non-core symptoms, “Personal devaluation” in MDD and “Confusion” in BD, displayed strong centrality. The network comparison test did not reveal significant differences in the network structure between MDD and BD. Conclusions: The absence of significant differences in the network structures between MDD and BD suggests that the underlying mechanisms of depressive symptoms may be similar across these disorders. The identified central symptoms, including “Depressed affect”, in both disorders and the distinct non-core symptoms in each highlight the complexity of the depressive symptomatology. Future research should focus on validating these symptoms as therapeutic targets and incorporate various methodologies, including non-metric dimension reduction techniques or canonical analysis.

23 April 2024 in Medicina
Verified
Journal Article
Open access
PDF file
JPJeehyung Pyo
Jeehyung Pyo
HLHyukjun Lee
Hyukjun Lee
JLJakyung Lee
Jakyung Lee
DLDaseul Lee
Daseul Lee
HYHyeona Yu
Hyeona Yu
DKDoh Kwan Kim
Doh Kwan Kim
Objective and objectives: Patients with cognitive disorders such as Alzheimer’s disease (AD) and mild cognitive impairment (MCI) frequently exhibit depressive symptoms. Depressive symptoms can be evaluated with various measures and questionnaires. The geriatric depression scale (GDS) is a scale that can be used to measure symptoms in geriatric age. Many questionnaires sum up symptom scales. However, core symptoms of depression in these patients and connections between these symptoms have not been fully explored yet. Thus, the objectives of this study were (1) to determine core symptoms of two cognitive disorders, Alzheimer’s disease and mild cognitive impairment, and (2) to investigate the network structure of depressive symptomatology in individuals with cognitive impairment in comparison with those with Alzheimer’s disease. Materials and Methods: This study encompassed 5354 patients with cognitive impairments such as Alzheimer’s disease (n 1889) and mild cognitive impairment (n = 3464). The geriatric depression scale, a self-administered questionnaire, was employed to assess depressive symptomatology. Using exploratory graph analysis (EGA), a network analysis was conducted, and the network structure was evaluated through regularized partial correlation models. To determine the centrality of depressive symptoms within each cohort, network parameters such as strength, betweenness, and closeness were examined. Additionally, to explore differences in the network structure between Alzheimer’s disease and mild cognitive impairment groups, a network comparison test was performed. Results: In the analysis of centrality indices, “worthlessness” was identified as the most central symptom in the geriatric depression scale among patients with Alzheimer’s disease, whereas “emptiness” was found to be the most central symptom in patients with mild cognitive impairment. Despite these differences in central symptoms, the comparative analysis showed no statistical difference in the overall network structure between Alzheimer’s disease and mild cognitive impairment groups. Conclusions: Findings of this study could contribute to a better understanding of the manifestation of depressive symptoms in patients with cognitive impairment. These results are expected to aid in identifying and prioritizing core symptoms in these patients. Further research should be conducted to explore potential interventions tailored to these core symptoms in patients with Alzheimer’s disease and mild cognitive impairment. Establishing core symptoms in those groups might have clinical importance in that appropriate treatment for neuropsychiatric symptoms in patients with cognitive impairment could help preclude progression to further impairment.

8 May 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
HLHyukjun Lee
Hyukjun Lee
JHJi Won Han
Ji Won Han
SSSeung Wan Suh
Seung Wan Suh
HYHee Won Yang
Hee Won Yang
DODae Jong Oh
Dae Jong Oh
KKKi Woong Kim
Ki Woong Kim
Background: Dementia is a major public health challenge, yet existing prediction models often overlook sleep-related symptoms, despite their known links to cognitive decline. Objective: To develop and validate a four-year Dementia Risk Score (DRS) incorporating self-reported sleep-related symptoms with demographic and clinical factors to predict all-cause dementia, including Alzheimer's disease. Methods: Data from 3082 Korean adults aged 60–79 years were analyzed. Predictors were selected using LASSO regression and included in a multivariate logistic regression model. A point-based scoring system, the DRS, was constructed from the model coefficients. Internal validation was conducted using bootstrapping and a separate dataset. Results: The DRS achieved robust predictive performance, with AUC values of 0.824 in the training set and 0.826 in the validation set. Key predictors included sleep disturbance, use of sleep medications, daytime dysfunction, leg discomfort, and urge to move legs. Conclusions: The DRS provides a practical, scalable tool for predicting dementia risk, supporting community-based screening and early intervention. External validation is needed to confirm its broader applicability.

13 October 2025 in ALPHA PSYCHIATRY
Verified
Journal Article
Open access
HYHyeona Yu
Hyeona Yu
YHYoukyung Hwangbo
Youkyung Hwangbo
DLDaseul Lee
Daseul Lee
JLJakyung Lee
Jakyung Lee
YKYuna Kim
Yuna Kim
Woojae MyungWoojae Myung
Woojae Myung
Objective: Borderline personality disorder (BPD) frequently co-occurs with affective disorders, such as major depressive disorder (MDD) and bipolar disorder (BD), yet the structure of BPD symptoms within these populations remains insufficiently characterized. This study utilizes network analysis to investigate the network structure of BPD symptoms in individuals with affective disorders. Methods: This study included 1323 participants: 783 individuals with affective disorders (MDD [n = 245], BD I [n = 120], BD II [n = 418]) and 540 controls without a history of psychiatric disorders. BPD symptoms were assessed using the Personality Assessment Inventory-Borderline Features Scale. A Gaussian graphical model was estimated using partial correlations among BPD symptoms, in which nodes correspond to individual symptoms and edges represent the relationships between them. Centrality analysis was subsequently conducted to compute strength, closeness, and betweenness centrality, providing insights into the relative importance and connectivity of individual symptoms within the network. Results: Analysis identified five distinct communities of BPD symptoms. The symptom “Feel empty” emerged as the most central trait across the affective disorder subgroups and the control group. Network comparison tests indicated no significant differences in network structure among the clinical subgroups, whereas a significant divergence was observed between the clinical and control groups. Conclusion: This study demonstrates that, although the symptom networks of BPD were largely comparable across affective disorder subgroups, structural differences emerged between the clinical and control groups. Notably, “Feel empty” consistently appeared as the most central symptom across all groups. These findings highlight the relevance of targeting “Feel empty” as a key focus for clinical intervention in affective disorders.

11 August 2025 in European Archives of Psychiatry and Clinical Neuroscience
Verified
Journal Article
Open access
HKHyeon Ji Kim
Hyeon Ji Kim
DLDaseul Lee
Daseul Lee
JKJinuk Kim
Jinuk Kim
NKNa Young Kim
Na Young Kim
SHSubeen Hong
Subeen Hong
JPJee Yoon Park
Jee Yoon Park
Background: Antenatal depression, which is prevalent during pregnancy, frequently continues into the postpartum period. We aimed to investigate the potential neurophysiological brain changes in women exhibiting antenatal depressive symptoms, using resting-state quantitative electroencephalography (qEEG) patterns as an objective indicator. Methods: Pregnant women with high-risk conditions were included and evaluated for antenatal depressive symptoms using the Edinburgh Postnatal Depression Scale (EPDS), then divided into groups based on an EPDS score of 10. Resting-state qEEG recordings were then obtained to assess relative power topography within classical frequency bands, comparing these measures across the two groups and examining their correlation with EPDS scores. Results: Among 36 participants, 12 scored ≥ 10 on the EPDS, indicative of significant depressive symptoms, while 24 scored < 10. Those with scores ≥ 10 exhibited heightened beta power in frontal areas (Fz and F4; p < 0.05), along with significant alpha and theta band asymmetry at the T3/T4 ( r = 0.383, p = 0.021) and P3/P4 ( r = 0.369, p = 0.027) sites respectively, positively correlating with EPDS scores. Limitations: Depressive symptoms were solely evaluated according to the EPDS, which is a screening tool. Additional limitations include the cross-sectional study design and the relatively small sample size, necessitating cautious interpretation of the results. Conclusion: The distinct qEEG patterns observed in women with EPDS scores ≥ 10 highlight the potential of qEEG as an objective indicator for assessing antenatal depression.

18 December 2025 in Medicina
Verified
Journal Article
Open access
PDF file
SKSarah Soonji Kwon
Sarah Soonji Kwon
HLHyukjun Lee
Hyukjun Lee
JLJakyung Lee
Jakyung Lee
JJJunwoo Jang
Junwoo Jang
DLDaseul Lee
Daseul Lee
Woojae MyungWoojae Myung
Woojae Myung
Background and Objectives: Anxiety is prevalent in patients with major depressive disorder (MDD) and bipolar disorder (BD). Understanding its interaction with mood disorders may provide deeper insight into symptom clustering, severity, and interventions. We compared the networks of MDD and BD using the Beck Anxiety Inventory (BAI) to identify central symptoms and interconnections. Materials and Methods: This cross-sectional study involved 815 individuals with MDD (n = 332) and BD (n = 483) who had clinically significant anxiety symptoms (BAI score > 8). Network analysis identified anxiety symptom clusters. Network centrality, stability, and comparison tests assessed the structural differences and global strength variations between the groups. Results: Both the MDD and BD networks showed strong interconnections among several BAI items and demonstrated stable centrality measures. Core symptoms with high centrality included “Losing control”, “Choking”, “Breathing”, “Unsteady”, and “Shaky” in both MDD and BD. Although no significant differences were found in the overall network structures between MDD and BD, the global strength of the network differed significantly, with MDD exhibiting modestly higher overall anxiety network connectivity than BD. Conclusions: Network clusters revealed aspects of both cognitive and somatic symptoms of anxiety. Although overall structures were similar between the groups, the MDD group showed stronger interconnections for central anxiety symptoms. Targeting central anxiety symptoms can enhance prevention and intervention strategies for mood disorders and improve clinical outcomes.